CLINICAL SUPPLY MANAGEMENT ARTICLES
The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.
-
How can a randomization and trial supply management approach to track and trace help improve its efficiency and efficacy? Find out the answer in this white paper.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Access the transcript from a recent Clinical Leader Live webinar where supply chain optimization experts shared best practices for streamlining shipments, reducing waste, and enhancing accountability.
-
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.